Quest Diagnostics Free Cash Flow — Historical Data
Quest Diagnostics (DGX) free cash flow was $1.4B in FY2025 (+50% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$1.4B
+50%
2024
$909M
+5%
2023
$864M
-34%
2022
$1.3B
-28%
2021
$1.8B
+15%
2020
$1.6B
+88%
2019
$843M
+3%
2018
$817M
-11%
2017
$923M
+12%
2016
$823M
+47%
2015
$558M
-12%
2014
$636M
+51%
2013
$421M
-58%
2012
$1.0B
+37%
2011
$734M
-20%
2010
$913M
+10%
2009
$830M
-2%
2008
$850M
+20%
2007
$708M
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q2 2026
$459M
Q1 2026
$164M
Q4 2025
$307M
Q3 2025
$419M
Q2 2025
$436M
Q1 2025
$197M
Q4 2024
$341M
Q3 2024
$250M
Q2 2024
$268M
Q1 2024
$50M
Q4 2023
$455M
Q3 2023
$102M
Source: DGX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.